193 related articles for article (PubMed ID: 12027807)
1. Luteolin, an emerging anti-cancer flavonoid, poisons eukaryotic DNA topoisomerase I.
Chowdhury AR; Sharma S; Mandal S; Goswami A; Mukhopadhyay S; Majumder HK
Biochem J; 2002 Sep; 366(Pt 2):653-61. PubMed ID: 12027807
[TBL] [Abstract][Full Text] [Related]
2. Betulinic acid, a potent inhibitor of eukaryotic topoisomerase I: identification of the inhibitory step, the major functional group responsible and development of more potent derivatives.
Chowdhury AR; Mandal S; Mittra B; Sharma S; Mukhopadhyay S; Majumder HK
Med Sci Monit; 2002 Jul; 8(7):BR254-65. PubMed ID: 12118187
[TBL] [Abstract][Full Text] [Related]
3. Betulinic acid, a catalytic inhibitor of topoisomerase I, inhibits reactive oxygen species-mediated apoptotic topoisomerase I-DNA cleavable complex formation in prostate cancer cells but does not affect the process of cell death.
Ganguly A; Das B; Roy A; Sen N; Dasgupta SB; Mukhopadhayay S; Majumder HK
Cancer Res; 2007 Dec; 67(24):11848-58. PubMed ID: 18089815
[TBL] [Abstract][Full Text] [Related]
4. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
[TBL] [Abstract][Full Text] [Related]
5. Cytotoxic effect of Plantago spp. on cancer cell lines.
Gálvez M; Martín-Cordero C; López-Lázaro M; Cortés F; Ayuso MJ
J Ethnopharmacol; 2003 Oct; 88(2-3):125-30. PubMed ID: 12963131
[TBL] [Abstract][Full Text] [Related]
6. Response of purified mitochondrial DNA topoisomerase I from bovine liver to camptothecin and m-AMSA.
Lin JH; Castora FJ
Arch Biochem Biophys; 1995 Dec; 324(2):293-9. PubMed ID: 8554321
[TBL] [Abstract][Full Text] [Related]
7. Luteolin, an abundant dietary component is a potent anti-leishmanial agent that acts by inducing topoisomerase II-mediated kinetoplast DNA cleavage leading to apoptosis.
Mittra B; Saha A; Chowdhury AR; Pal C; Mandal S; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
Mol Med; 2000 Jun; 6(6):527-41. PubMed ID: 10972088
[TBL] [Abstract][Full Text] [Related]
8. Flavonoids in Helichrysum pamphylicum inhibit mammalian type I DNA topoisomerase.
Topcu Z; Ozturk B; Kucukoglu O; Kilinc E
Z Naturforsch C J Biosci; 2008; 63(1-2):69-74. PubMed ID: 18386491
[TBL] [Abstract][Full Text] [Related]
9. Chinese hamster ovary cells resistant to the topoisomerase II catalytic inhibitor ICRF-159: a Tyr49Phe mutation confers high-level resistance to bisdioxopiperazines.
Sehested M; Wessel I; Jensen LH; Holm B; Oliveri RS; Kenwrick S; Creighton AM; Nitiss JL; Jensen PB
Cancer Res; 1998 Apr; 58(7):1460-8. PubMed ID: 9537249
[TBL] [Abstract][Full Text] [Related]
10. F 11782, a novel epipodophylloid non-intercalating dual catalytic inhibitor of topoisomerases I and II with an original mechanism of action.
Perrin D; van Hille B; Barret JM; Kruczynski A; Etiévant C; Imbert T; Hill BT
Biochem Pharmacol; 2000 Apr; 59(7):807-19. PubMed ID: 10718339
[TBL] [Abstract][Full Text] [Related]
11. Induction of topoisomerase II-mediated DNA cleavage by a protoberberine alkaloid, berberrubine.
Kim SA; Kwon Y; Kim JH; Muller MT; Chung IK
Biochemistry; 1998 Nov; 37(46):16316-24. PubMed ID: 9819224
[TBL] [Abstract][Full Text] [Related]
12. Quinolones share a common interaction domain on topoisomerase II with other DNA cleavage-enhancing antineoplastic drugs.
Elsea SH; Westergaard M; Burden DA; Lomenick JP; Osheroff N
Biochemistry; 1997 Mar; 36(10):2919-24. PubMed ID: 9062121
[TBL] [Abstract][Full Text] [Related]
13. A gel electrophoresis assay for the simultaneous determination of topoisomerase I inhibition and DNA intercalation.
Webb MR; Ebeler SE
Anal Biochem; 2003 Oct; 321(1):22-30. PubMed ID: 12963051
[TBL] [Abstract][Full Text] [Related]
14. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
[TBL] [Abstract][Full Text] [Related]
15. Fluorometric assays for DNA topoisomerases and topoisomerase-targeted drugs: quantitation of catalytic activity and DNA cleavage.
Andrea JE; Adachi K; Morgan AR
Mol Pharmacol; 1991 Oct; 40(4):495-501. PubMed ID: 1656189
[TBL] [Abstract][Full Text] [Related]
16. Exploiting mechanistic differences between drug classes to define functional drug interaction domains on topoisomerase II. Evidence that several diverse DNA cleavage-enhancing agents share a common site of action on the enzyme.
Corbett AH; Hong D; Osheroff N
J Biol Chem; 1993 Jul; 268(19):14394-8. PubMed ID: 8390992
[TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of topoisomerase IB inhibition and DNA intercalation by flavonoids and similar compounds: structural determinates of activity.
Webb MR; Ebeler SE
Biochem J; 2004 Dec; 384(Pt 3):527-41. PubMed ID: 15312049
[TBL] [Abstract][Full Text] [Related]
18. Aurintricarboxylic acid, a putative inhibitor of apoptosis, is a potent inhibitor of DNA topoisomerase II in vitro and in Chinese hamster fibrosarcoma cells.
Benchokroun Y; Couprie J; Larsen AK
Biochem Pharmacol; 1995 Jan; 49(3):305-13. PubMed ID: 7857317
[TBL] [Abstract][Full Text] [Related]
19. Antitumor activity of ER-37328, a novel carbazole topoisomerase II inhibitor.
Nakamura K; Sugumi H; Yamaguchi A; Uenaka T; Kotake Y; Okada T; Kamata J; Niijima J; Nagasu T; Koyanagi N; Yoshino H; Kitoh K; Yoshimatsu K
Mol Cancer Ther; 2002 Jan; 1(3):169-75. PubMed ID: 12467211
[TBL] [Abstract][Full Text] [Related]
20. Mechanism of cytotoxicity of N-[2-(dimethylamino)ethyl] acridine-4-carboxamide and of its 7-chloro derivative: the roles of topoisomerases I and II.
Bridewell DJ; Finlay GJ; Baguley BC
Cancer Chemother Pharmacol; 1999; 43(4):302-8. PubMed ID: 10071981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]